Follow
Davoud Asgari
Davoud Asgari
chemQ bioscience LLC
Verified email at chemqbioscience.com - Homepage
Title
Cited by
Cited by
Year
Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer
MH Majd, D Asgari, J Barar, H Valizadeh, V Kafil, A Abadpour, ...
Colloids and Surfaces B: Biointerfaces 106, 117-125, 2013
1142013
Efficient Synthesis of 1,1‘-Binaphthyl and 2,2‘-Bi-o-tolyl-2,2‘-bis(oxazoline)s and Preliminary Use for the Catalytic Asymmetric Allylic Oxidation of Cyclohexene
MB Andrus, D Asgari, JA Sclafani
The Journal of Organic Chemistry 62 (26), 9365-9368, 1997
1141997
Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin
A Akbarzadeh, N Zarghami, H Mikaeili, D Asgari, AM Goganian, ...
Nanotechnology, science and applications, 13-25, 2012
962012
Asymmetric allylic oxidation with biarylbisoxazoline-copper (I) catalysis
MB Andrus, D Asgari
Tetrahedron 56 (32), 5775-5780, 2000
922000
Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells
J Barar, V Kafil, MH Majd, A Barzegari, S Khani, M Johari-Ahar, D Asgari, ...
Journal of nanobiotechnology 13, 1-16, 2015
852015
Spectroscopic studies on the interaction between erlotinib hydrochloride and bovine serum albumin
F Rasoulzadeh, D Asgari, A Naseri, MR Rashidi
DARU Journal of Pharmaceutical Sciences 18 (3), 179, 2010
782010
Spectroscopic studies on the interaction between erlotinib hydrochloride and bovine serum albumin
F Rasoulzadeh, D Asgari, A Naseri, MR Rashidi
DARU Journal of Pharmaceutical Sciences 18 (3), 179, 2010
782010
2-Hydroxy-4, 6-diamino-[1, 3, 5] triazines: a novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors
N Baindur, N Chadha, BM Brandt, D Asgari, RJ Patch, C Schalk-HiHi, ...
Journal of medicinal chemistry 48 (6), 1717-1720, 2005
692005
Substituted thieno [3, 2-D] pyrimidines as Rho kinase inhibitors
D Nagarathnam, U Khire, D Asgari, J Shao, XG Liu, C Wang, B Hart, ...
US Patent 7,648,986, 2010
672010
Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles
M Heidari Majd, D Asgari, J Barar, H Valizadeh, V Kafil, G Coukos, ...
Journal of drug targeting 21 (4), 328-340, 2013
662013
A facile synthesis of novel pyrrolizidines under classical and ultrasonic conditions
K Jadidi, R Gharemanzadeh, M Mehrdad, HR Darabi, HR Khavasi, ...
Ultrasonics Sonochemistry 15 (2), 124-128, 2008
622008
Targeted fluoromagnetic nanoparticles for imaging of breast cancer mcf-7 cells
MH Majd, J Barar, D Asgari, H Valizadeh, MR Rashidi, V Kafil, J Shahbazi, ...
Advanced pharmaceutical bulletin 3 (1), 189, 2013
522013
Targeted fluoromagnetic nanoparticles for imaging of breast cancer mcf-7 cells
MH Majd, J Barar, D Asgari, H Valizadeh, MR Rashidi, V Kafil, J Shahbazi, ...
Advanced pharmaceutical bulletin 3 (1), 189, 2013
522013
Rho-kinase inhibitors
D Nagarathnam, U Khire, D Asgari, J Shao, XG Liu, C Wang, B Hart, ...
US Patent App. 10/339,393, 2004
482004
Modified synthesis of erlotinib hydrochloride
L Barghi, A Aghanejad, H Valizadeh, J Barar, D Asgari
Advanced pharmaceutical bulletin 2 (1), 119, 2012
472012
Modified synthesis of erlotinib hydrochloride
L Barghi, A Aghanejad, H Valizadeh, J Barar, D Asgari
Advanced pharmaceutical bulletin 2 (1), 119, 2012
472012
An improved convergent approach for synthesis of erlotinib, a tyrosine kinase inhibitor, via a ring closure reaction of phenyl benzamidine intermediate
D Asgari, A Aghanejad, JS Mojarrad
Bulletin of the Korean chemical society 32 (3), 909-914, 2011
402011
Aptamer-based nanosensors: juglone as an attached-redox molecule for detection of small molecules
M Saberian, H Hamzeiy, A Aghanejad, D Asgari
BioImpacts: BI 1 (1), 31, 2011
392011
C-fms kinase inhibitors
MR Player, N Baindur, B Brandt, N Chadha, RJ Patch, D Asgari, ...
US Patent 7,429,603, 2008
342008
c-fms kinase inhibitors
MR Player, N Baindur, B Brandt, N Chadha, RJ Patch, D Asgari, ...
US Patent 7,427,683, 2008
342008
The system can't perform the operation now. Try again later.
Articles 1–20